ibuprofen has been researched along with Intestinal Perforation in 10 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Intestinal Perforation: Opening or penetration through the wall of the INTESTINES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To discuss intestinal side effects of ibuprofen in the treatment of patent ductus arteriosus, after having observed two cases of spontaneous intestinal perforation following ibuprofen treatment." | 7.72 | Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two very-low-birthweight infants. ( Demir, K; Duman, N; Gurcu, O; Kumral, A; Ozkan, H; Tatli, MM, 2004) |
| "Gastrointestinal complications observed in infants treated with ibuprofen for PDA including gastrointestinal perforations occur in less mature infants." | 3.96 | Adverse events related to ibuprofen treatment for patent ductus arteriosus in premature neonates. ( Berthiller, J; Bouamari, H; Claris, O; Ndour, D; Nguyen, KA; Plaisant, F, 2020) |
| "To compare the incidence of medical closure of patent ductus arteriosus (PDA) and adverse events (acute renal dysfunction, necrotizing enterocolitis, spontaneous intestinal perforation, and gastrointestinal bleeding) between preterm infants who received indomethacin and ibuprofen for the treatment of PDA." | 3.79 | Effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus in preterm infants. ( Bali, V; Harabor, A; Kamaluddeen, M; Sivanandan, S; Soraisham, AS, 2013) |
| "To discuss intestinal side effects of ibuprofen in the treatment of patent ductus arteriosus, after having observed two cases of spontaneous intestinal perforation following ibuprofen treatment." | 3.72 | Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two very-low-birthweight infants. ( Demir, K; Duman, N; Gurcu, O; Kumral, A; Ozkan, H; Tatli, MM, 2004) |
| " Use of low risk drugs in low dosage as first line treatment would substantially reduce the morbidity and mortality due to serious gastrointestinal toxicity from these drugs." | 2.39 | Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. ( Carson, JL; Fries, JT; Garcia Rodriguez, LA; Griffin, M; Hawkey, C; Henry, D; Hill, S; Lim, LL; Logan, R; Moride, Y; Perez Gutthann, S; Savage, R, 1996) |
| "Management of persistently patent ductus arteriosus (PDA) in extremely low-birth-weight infants (ELBWIs) requires attention due to the risk of tissue hypoperfusion." | 1.91 | Association between gastrointestinal perforation and patent ductus arteriosus in extremely-low-birth-weight infants: a retrospective study of our decade-long experience. ( Ibara, S; Ieiri, S; Ikee, T; Ikoma, S; Kawano, M; Kawano, T; Machigashira, S; Masuya, R; Matsukubo, M; Murakami, M; Muto, M; Nakame, K; Noguchi, H; Sugita, K; Torikai, M, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muto, M | 1 |
| Sugita, K | 1 |
| Murakami, M | 1 |
| Ikoma, S | 1 |
| Kawano, M | 1 |
| Masuya, R | 1 |
| Matsukubo, M | 1 |
| Kawano, T | 1 |
| Machigashira, S | 1 |
| Nakame, K | 1 |
| Torikai, M | 1 |
| Ikee, T | 1 |
| Noguchi, H | 1 |
| Ibara, S | 1 |
| Ieiri, S | 1 |
| Tuteja, A | 1 |
| Pournami, F | 1 |
| Kolisambeevi, AA | 1 |
| Nandakumar, A | 1 |
| Prabhakar, J | 1 |
| Jain, N | 1 |
| Ndour, D | 1 |
| Bouamari, H | 1 |
| Berthiller, J | 1 |
| Claris, O | 1 |
| Plaisant, F | 1 |
| Nguyen, KA | 1 |
| Yehiyan, A | 1 |
| Barman, S | 1 |
| Varia, H | 1 |
| Pettit, S | 1 |
| Chan, NM | 1 |
| Law, CW | 1 |
| Kwan, KF | 1 |
| Rao, R | 1 |
| Bryowsky, K | 1 |
| Mao, J | 1 |
| Bunton, D | 1 |
| McPherson, C | 1 |
| Mathur, A | 1 |
| Sivanandan, S | 1 |
| Bali, V | 1 |
| Soraisham, AS | 1 |
| Harabor, A | 1 |
| Kamaluddeen, M | 1 |
| Tatli, MM | 1 |
| Kumral, A | 1 |
| Duman, N | 1 |
| Demir, K | 1 |
| Gurcu, O | 1 |
| Ozkan, H | 1 |
| Clarke, SF | 1 |
| Arepalli, N | 1 |
| Armstrong, C | 1 |
| Dargan, PI | 1 |
| Henry, D | 1 |
| Lim, LL | 1 |
| Garcia Rodriguez, LA | 1 |
| Perez Gutthann, S | 1 |
| Carson, JL | 1 |
| Griffin, M | 1 |
| Savage, R | 1 |
| Logan, R | 1 |
| Moride, Y | 1 |
| Hawkey, C | 1 |
| Hill, S | 1 |
| Fries, JT | 1 |
1 review available for ibuprofen and Intestinal Perforation
| Article | Year |
|---|---|
Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cohort Studies; Dose-Response Relatio | 1996 |
9 other studies available for ibuprofen and Intestinal Perforation
| Article | Year |
|---|---|
Association between gastrointestinal perforation and patent ductus arteriosus in extremely-low-birth-weight infants: a retrospective study of our decade-long experience.
Topics: Ductus Arteriosus, Patent; Enterocolitis, Necrotizing; Humans; Ibuprofen; Indomethacin; Infant, Extr | 2023 |
Paracetamol for Patent Ductus Arteriosus Closure: High Osmolality of Enteral Form and Spontaneous Intestinal Perforation.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Ductus Arteriosus, Patent; Humans; Ibuprofen; Intestinal Pe | 2020 |
Adverse events related to ibuprofen treatment for patent ductus arteriosus in premature neonates.
Topics: Cyclooxygenase Inhibitors; Ductus Arteriosus, Patent; Female; Gestational Age; Humans; Ibuprofen; In | 2020 |
Short-course high-dose ibuprofen causing both early and delayed jejunal perforations in a non-smoking man.
Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Back Pain; Humans; Ibuprofen; Intestinal Pe | 2017 |
Ibuprofen versus indomethacin treatment of patent ductus arteriosus: comparative effectiveness and complications.
Topics: Bronchopulmonary Dysplasia; Creatinine; Ductus Arteriosus, Patent; Female; Humans; Ibuprofen; Indome | 2014 |
Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus.
Topics: Cohort Studies; Confidence Intervals; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; D | 2011 |
Effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus in preterm infants.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Ductus Arteriosus, Patent; Enterocolitis, Necrotizing; Fema | 2013 |
Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two very-low-birthweight infants.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Ductus Arteriosus, Patent; Female; Hu | 2004 |
Duodenal perforation after ibuprofen overdose.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Drug Overdose; Duodenal Diseases; Duodenal Ulce | 2004 |